Lead sponsor

Geisinger Clinic

2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.

2

Trials led

0

Active

18

Total enrollment

2

Sites

Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.

Portfolio

How this sponsor's trials break down

Trials by phase

Phase 3
1
Phase 4
1

Trials by status

Terminated
2

Trials led

RAISE-KTBMI 25-45Ph 3Terminated15
NOVO-GLP1Ph 4Terminated3